Superior Cluneal Nerve Entrapment Syndrome, Kinesiotaping and Myofascial Release Techniques

Not Applicable

Completed

• Conditions: Superior Cluneal Nerve Entrapment

• Registration Number: NCT06672744
• Lead Sponsor: Savaş Karpuz

Brief Summary

Myofascial release techniques and/or kinesiotaping may be effective in the treatment of superior cluneal nerve impingement syndrome ?

Detailed Description

Not available

Study Timeline

• Study Start: 2022-08-15
• Primary Completion: 2024-08-15
• Study Completion: 2024-08-16
• Study First Submitted: 2024-10-31
• Status Verified: 2024-11
• Study First Submitted QC: 2024-11-01
• Last Update Submitted: 2024-11-01
• Study First Posted: 2024-11-04
• Last Update Posted: 2024-11-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 75

Inclusion Criteria

• patients diagnosed with superior cluneal nerve entrapment syndrome

Exclusion Criteria

• those with communication problems
• those who also described pain in the mid-lumbar region

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Visual Analoque Scale	Before treatment, immediately after treatment, 1 month after the end of treatment	Visual Analoque Scale is a scale consisting of a single 10 cm line and assesses the intensity of pain. Patients were asked to rate the level of pain after being informed that the beginning point on the scale represented no pain and the end point represented the most excruciating pain they had ever experienced
The Roland-Morris Disability Questionnaire	Before treatment, immediately after treatment, 1 month after the end of treatment	The Roland-Morris Disability Questionnaire is a questionnaire developed to assess functional disabilities in patients with low back pain \[15\]. In the questionnaire consisting of 24 sentences about functional disabilities, patients are asked to answer each sentence as yes if it fits their situation and no if it does not. Yes answers are calculated as '1' and no answers as '0' points, resulting in a total score between 0-24, with a higher score indicating more disability.

Secondary Outcome Measures

Name	Time	Method
SF-36 Quality of Life Scale	Before treatment, immediately after treatment, 1 month after the end of treatment	SF-36 Quality of Life Scale is a general quality of life scale frequently used in clinical research. The scale consists of 36 items, which measure 8 different dimensions: physical functions, social functions, role inhibition due to physical problems, physical pain, mental health, role inhibition due to emotional problems, life energy, general health perception. The subscales assess health on a scale of 0 to 100, with higher scores indicating good health quality.

Trial Locations

Locations (1)

Konya Beyhekim Training and Research Hospital; 🇹🇷 Konya, Selçuklu, Turkey